These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21344707)

  • 1. Risk adjustment and risk equalization: what needs to be done?
    Van de Ven WP
    Health Econ Policy Law; 2011 Jan; 6(1):147-56. PubMed ID: 21344707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk equalization in The Netherlands: an empirical evaluation.
    Van Kleef RC; Van Vliet RC; Van de Ven WP
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):829-39. PubMed ID: 24175733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk selection in a regulated health insurance market: a review of the concept, possibilities and effects.
    van Kleef RC; van de Ven WP; van Vliet RC
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):743-52. PubMed ID: 24219050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public and private health insurance in Germany: the ignored risk selection problem.
    Grunow M; Nuscheler R
    Health Econ; 2014 Jun; 23(6):670-87. PubMed ID: 23696240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk adjustment and the fear of markets: the case of Belgium.
    Schokkaert E; Van de Voorde C
    Health Care Manag Sci; 2000 Feb; 3(2):121-30. PubMed ID: 10780280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Notes on the planned German health fund model].
    Robra BP; Mayrhofer T
    Gesundheitswesen; 2006 Oct; 68(10):650-2. PubMed ID: 17099827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "health benefit basket" in the Netherlands.
    Stolk EA; Rutten FF
    Eur J Health Econ; 2005 Dec; Suppl(Suppl 1):53-7. PubMed ID: 16270209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk structure compensation in Germany's statutory health insurance.
    Busse R
    Eur J Public Health; 2001 Jun; 11(2):174-7. PubMed ID: 11420805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subacute care funding in the firing line.
    Poulos CJ; Eagar K; Faux SG; Estell JJ; Crotty M
    Med J Aust; 2013 Jul; 199(2):92-3. PubMed ID: 23879492
    [No Abstract]   [Full Text] [Related]  

  • 10. The three branches of Government and financing of the Brazilian Unified National Health System: 2015 in review.
    Santos AO; Delduque MC; Alves SM
    Cad Saude Publica; 2016 Jan; 32(1):. PubMed ID: 26886183
    [No Abstract]   [Full Text] [Related]  

  • 11. Hybrid risk adjustment for pharmaceutical benefits.
    García-Goñi M; Ibern P; Inoriza JM
    Eur J Health Econ; 2009 Jul; 10(3):299-308. PubMed ID: 19011914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health-based risk adjustment. Effects and side effects].
    Jahn R; Schillo S; Wasem J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):624-32. PubMed ID: 22526850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health financing in Africa.
    Jones JS
    S Afr Med J; 2006 Jun; 96(6):496-7. PubMed ID: 16858884
    [No Abstract]   [Full Text] [Related]  

  • 14. Overpaying morbidity adjusters in risk equalization models.
    van Kleef RC; van Vliet RC; van de Ven WP
    Eur J Health Econ; 2016 Sep; 17(7):885-95. PubMed ID: 26420555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk adjusted premium subsidies and risk sharing: key elements of the competitive sickness fund market in the Netherlands.
    Lamers LM; van Vliet RC; van de Ven WP
    Health Policy; 2003 Jul; 65(1):49-62. PubMed ID: 12818745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demand-side strategies to deal with moral hazard in public insurance for long-term care.
    Bakx P; Chernichovsky D; Paolucci F; Schokkaert E; Trottmann M; Wasem J; Schut F
    J Health Serv Res Policy; 2015 Jul; 20(3):170-6. PubMed ID: 25770020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Planning and management of human resources in the context of public financing of health services: the Canadian experience].
    Godue C; Dussault G
    Educ Med Salud; 1992; 26(4):453-68. PubMed ID: 1464247
    [No Abstract]   [Full Text] [Related]  

  • 18. Hospitals as businesses.
    Timbrell DR
    Health Law Can; 1993; 13(4):224-6. PubMed ID: 10126869
    [No Abstract]   [Full Text] [Related]  

  • 19. Those who repeat history are doomed to condemn it.
    Timbrell DR
    Healthc Manage Forum; 1993; 6(2):49-53. PubMed ID: 10126763
    [No Abstract]   [Full Text] [Related]  

  • 20. Health reform and activity-based funding.
    Solomon S
    Med J Aust; 2014 Jun; 200(10):564. PubMed ID: 24882476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.